By strengthening heart contractions, Impulse’s device could improve quality of life, restore functional capacity and enhance tolerance for exercise.
Impulse Dynamics raises $158M to commercialize heart failure device Read More »
El panorama de las apuestas deportivas en línea ha evolucionado significativamente hacia 2025, con casas de apuestas que compiten ferozmente por captar nuevos usuarios mediante bonificaciones cada vez más atractivas. Según datos recientes de la Asociación Internacional de …
Métodos de Primer Depósito que Maximizan Bonificaciones en Casas de Apuestas Read More »
The robotic surgery market leader’s single port system can now be used in inguinal hernia repair, gallbladder removal and appendectomy procedures.
Intuitive wins 3 new indications for da Vinci SP system Read More »
La ruleta, uno de los juegos de casino más emblemáticos, continúa evolucionando con opciones de apuestas laterales que añaden capas de emoción sin perjudicar significativamente los requisitos de apuesta. Para 2025, el mercado de juegos de azar en España proy …
Apuestas Laterales de Ruleta: Entretenimiento Responsable Sin Comprometer el Juego Read More »
Amy Schulman is the second veteran of the pharmaceutical industry that Elevance has added to its board this year.
Ex-Pfizer executive joins Elevance’s board as insurer pursues pharmacy experience Read More »
Hammons has served as interim CEO of the hospital operator since October. Also on Wednesday, Jason Johnson, previously CHS’ chief accounting officer, was appointed CFO.
The proposed cybersecurity rule, released during the waning days of the Biden administration, would add “substantial new financial burdens” on providers, the groups wrote to the HHS.
Provider groups urge Trump administration to drop proposed HIPAA update Read More »
The plan to extend the more generous financial assistance for three years is expected to go up for a vote in the Senate Thursday, alongside a Republican alternative that would replace the subsidies.
Democrats’ ACA subsidy extension adds $83B to deficit, boosts insured: CBO Read More »
The FDA is becoming deeply compromised and increasingly at risk of being permanently transformed in ways contrary to its mission, history and culture.
Opinion: FDA Is Built on Predictability and Expertise, Not Norm-Breaking Read More »
Analysts were hoping for a safety profile similar to what was achieved in Phase II but an abnormal sense of touch, called dysesthesia, has emerged in the late-stage TRIUMPH-4 trial.
